Medication Problems in Older, Newly Diagnosed Cancer Patients in Canada: How Common are They? A Prospective Pilot Study

被引:60
|
作者
Puts, Maribie T. E. [1 ,3 ]
Costa-Lima, Beatriz [1 ]
Monette, Johanne [1 ,2 ]
Girre, Veronique [2 ,4 ]
Wolfson, Christbia [3 ,5 ]
Batist, Gerald [6 ]
Bergman, Howard [1 ,2 ]
机构
[1] McGill Univ, Ctr Clin Epidemiol & Community, Solidage Res Grp Frailty & Aging, Montreal, PQ, Canada
[2] McGill Univ, Sir Mortimer B Davis Jewish Hosp, Div Geriatr Med, Montreal, PQ, Canada
[3] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[4] Inst Curie, Dept Med Oncol, Paris, France
[5] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada
[6] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada
关键词
PHYSICAL PERFORMANCE-MEASURES; POTENTIAL-DRUG INTERACTIONS; BREAST-CANCER; COMORBIDITY INDEX; DEPRESSION SCALE; ELDERLY VETERANS; HOSPITAL ANXIETY; HEALTH; ADULTS; POLYPHARMACY;
D O I
10.2165/00002512-200926060-00008
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Prescribing for older patients is challenging and complex. Cancer patients are at a considerable increased risk of drug-related problems because they typically receive a large number of medications during their cancer treatment, both for the cancer itself and for supportive care. Few studies have examined the scope of this problem in older newly diagnosed cancer patients. Objective: To investigate the number and severity of potential drug problems and factors associated with the occurrence of potential drug problems in older newly diagnosed cancer patients. Methods: This prospective pilot study was conducted in newly diagnosed cancer patients aged >= 65 years recruited in the Segal Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada. Vigilance Sante software was used to identify the presence and type of potential drug problems. Logistic regression analyses were used to identify factors associated with the presence of one or more severe or moderately severe potential drug problems. Results: There were 112 participants with a mean age of 74.2 years, and 70% were women. A total of 103 patients (92%) were taking medications. The median number of medications per patient was 5 (interquartile range 3-9) and a total of 247 potential drug problems were identified. Sixty-four patients (62.1%) had a potential drug problem of any level of severity and 49 patients had a potential moderate/severe drug problem identified (47.6%). Two (0.8%) potential drug problems of the most severe level were identified, 122 warnings (49.4%) of all potential problems were of moderate severity and 123 warnings (49.8%) were at the least severe level. Factors associated with having one or more moderate/severe potential drug problems were taking five or more drugs and age >= 76 years. Conclusion: The majority of older newly diagnosed cancer patients in this study were taking at least one medication and the median number of medications per patient was 5. Published studies have shown that medication problems are common in community-dwelling older persons, but they are mostly of low severity. In this group of older newly diagnosed cancer patients, potential medication problems were also found to be common; however, half of the potential problems identified were of moderate severity.
引用
收藏
页码:519 / 536
页数:18
相关论文
共 50 条
  • [21] Comprehensive Geriatric Assessment and Geriatric Intervention in Older Patients with Newly Diagnosed Lymphoma: A Prospective Study
    Lopez Garcia, Alberto
    Isabel Hormigo, Ana
    Mahillo, Ignacio
    Askari, Elham
    Morillo, Daniel
    Perez Saez, Maria Angeles
    Prieto, Elena
    Riesco, Miriam
    Urrutia, Celia
    Martinez Peromingo, Francisco Javier
    Gonzalez Montalvo, Juan Ignacio
    Cordoba, Raul
    BLOOD, 2023, 142
  • [22] Characteristics of older newly diagnosed cancer patients refusing cancer treatments
    Martine T. E. Puts
    Johanne Monette
    Veronique Girre
    Christina Wolfson
    Michèle Monette
    Gerald Batist
    Howard Bergman
    Supportive Care in Cancer, 2010, 18 : 969 - 974
  • [23] Characteristics of older newly diagnosed cancer patients refusing cancer treatments
    Puts, Martine T. E.
    Monette, Johanne
    Girre, Veronique
    Wolfson, Christina
    Monette, Michele
    Batist, Gerald
    Bergman, Howard
    SUPPORTIVE CARE IN CANCER, 2010, 18 (08) : 969 - 974
  • [24] Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study
    Extermann, M
    Chen, H
    Cantor, AB
    Corcoran, MB
    Meyer, J
    Grendys, E
    Cavanaugh, D
    Antonek, S
    Camarata, A
    Haley, WE
    Balducci, L
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (11) : 1466 - 1473
  • [25] Can older cancer patients tolerate chemotherapy? A prospective pilot study
    Chen, HB
    Cantor, A
    Meyer, J
    Corcoran, MB
    Grendys, E
    Cavanaugh, D
    Camarata, A
    Haley, W
    Balducci, L
    Extermann, M
    CANCER, 2003, 97 (04) : 1107 - 1114
  • [26] Hypercortisolism in Newly Diagnosed Type 2 Diabetes: A Prospective Study of 384 Newly Diagnosed Patients
    Steffensen, Charlotte
    Dekkers, Olaf M.
    Lyhne, Johanne
    Pedersen, Bodil G.
    Rasmussen, Finn
    Rungby, Jorgen
    Poulsen, Per Logstrup
    Jorgensen, Jens Otto Lunde
    HORMONE AND METABOLIC RESEARCH, 2019, 51 (01) : 62 - 68
  • [27] How to study determinants related to medication adherence in newly diagnosed polyarthritis patients for the development of a prediction instrument
    Pasma, Annelieke
    Hazes, Johanna M. W.
    Luime, Jolanda J.
    Busschbach, Jan J. V.
    van't Spijker, Adriaan
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 1437 - 1447
  • [28] Prospective Multicenter Study of Bone Scintigraphy in Consecutive Patients With Newly Diagnosed Prostate Cancer
    Zacho, Helle Damgaard
    Barsi, Tamas
    Mortensen, Jesper C.
    Mogensen, Maureen K.
    Bertelsen, Henrik
    Josephsen, Norah
    Petersen, Lars J.
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (01) : 26 - 31
  • [29] Latent Tuberculosis in Newly Diagnosed Lung Cancer Patients. An Spanish Prospective Study
    Martinez Moreno, E.
    Esteban Esteban, C.
    Irigoyen, A.
    Munoz Platon, E.
    Alvarez Cabellos, R.
    Andrade Santiago, J.
    Burgueno Lorenzo, I.
    Cardenas, J. D.
    Martinez Barroso, K.
    Santos, A. K.
    Borregon Rivilla, M.
    Trujillo Alba, B.
    Chacon Lopez-Muniz, J. I.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1989 - S1990
  • [30] A Prospective Pilot Study of Ixazomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed or Relapsed/Refractory POEMS Syndrome
    Dispenzieri, Angela
    Mauermann, Michelle
    Laplant, Betsy
    Lacy, Martha Q.
    Go, Ronald S.
    Kapoor, Prashant
    Hwa, Yi L.
    Fonder, Amie
    Hobbs, Miriam A.
    Buadi, Francis K.
    Hayman, Suzanne R.
    Leung, Nelson
    Lust, John A.
    Dingli, David
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Warsame, Rahma M.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    Gertz, Morie A.
    BLOOD, 2019, 134